All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the Lymphoma Coalition.

  TRANSLATE

The lym Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the lym Hub cannot guarantee the accuracy of translated content. The lym and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The Lymphoma & CLL Hub is an independent medical education platform, sponsored by AbbVie, BeOne Medicines, Johnson & Johnson, Roche and sobi, and supported through educational grants from Bristol Myers Squibb, Incyte and Lilly. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Francesc Bosch outlines what he will be discussing at the virtual Lymphoma Hub Satellite Symposium

Share:

Featured:

Francesc BoschFrancesc Bosch

Nov 4, 2020


The Lymphoma Hub looks forward to hosting a virtual Satellite Symposium at this year’s European School of Haematology (ESH) ‘2nd How to Diagnose and Treat: Lymphoma’ conference. The symposium will take place on Sunday, November 8, 2020, at 15:5016:50 CET.

Francesc Bosch outlines what he will be discussing at the virtual Lymphoma Hub Satellite Symposium

Francesc Bosch, University Hospital Vall d'Hebron, Barcelona, ES, outlines what he will be discussing at the virtual symposium where he will be joined by Marie José Kersten, Astrid Pavlovsky, Kieron Dunleavy, and Gilles Salles.

Your opinion matters

In your experience, when do most CRS/ICANS events occur after lisocabtagene maraleucel infusion?